ABSTRACT
Imagine a fine sunny day in June. In the research conference room of Miraculo Corporation, the head of research, Dr. William Wonder is meeting with the discovery team for Project X. Project X is a high profile, AAA priority rated project, the objective of which is to establish lead compounds for the treatment of a common and poorly treated disabling disease. Scientists at Miraculo believe that, with their academic collaborators, they have developed unique insights into the underlying biochemical pathology of the disease.
